# Palisade Bio, Inc.: filings

PALI · Nasdaq · CIK 1357459 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pali.md) · [Financials](/companies/pali/financials.md) · [Filings](/companies/pali/filings.md) · [Insiders](/companies/pali/insiders.md)

## Reports and events: 461 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 327, 4 259, 10-Q 53, 424B3 46, CORRESP 38, EFFECT 28, 424B5 26, UPLOAD 26, 3 25, DEF 14A 24, 425 22, DEFA14A 22, SC 13G/A 22, S-3 19, 10-K 18, SC 13G 18, SCHEDULE 13G/A 14, S-1/A 13, D 12, PRE 14A 12, S-3/A 11, 4/A 10, S-8 10, SCHEDULE 13G 10, 5 9, S-1 9, 8-K/A 7, ARS 4, FWP 4, SC 13D 4, 10-Q/A 3, 144 3, 424B4 3, 3/A 2, DRS 2, NT 10-Q 2, POS EX 2, RW 2, S-1MEF 2, S-4/A 2, SC 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 25 1, 424B2 1, 8-A12B 1, CERTNAS 1, D/A 1, DEFR14A 1, NT 10-K 1, POS462B 1, POS AM 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 16:18 ET | [8-K](/filings/0001357459-26-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001357459-26-000017 |
| 2026-08-10 | 16:06 ET | [10-Q](/filings/0001357459-26-000016.md) | Quarterly report, period 2026-06-30 | 0001357459-26-000016 |
| 2026-06-11 | 17:23 ET | [8-K](/filings/0001493152-26-028322.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-028322 |
| 2026-05-12 | 16:14 ET | [8-K](/filings/0001357459-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001357459-26-000011 |
| 2026-05-12 | 16:04 ET | [10-Q](/filings/0001357459-26-000010.md) | Quarterly report, period 2026-03-31 | 0001357459-26-000010 |
| 2026-04-29 | 16:49 ET | [DEF 14A](/filings/0001493152-26-019629.md) | Proxy statement, period 2026-04-29 | 0001493152-26-019629 |
| 2026-04-02 | 08:34 ET | [8-K](/filings/0001493152-26-014822.md) | 8.01 Other events | 0001493152-26-014822 |
| 2026-03-20 | 16:22 ET | [10-K](/filings/0001357459-26-000004.md) | Annual report, period 2025-12-31 | 0001357459-26-000004 |
| 2025-12-04 | 16:40 ET | [8-K](/filings/0001493152-25-026195.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-026195 |
| 2025-11-10 | 16:14 ET | [10-Q](/filings/0001193125-25-274262.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274262 |
| 2025-10-28 | 09:34 ET | [DEF 14A](/filings/0001493152-25-019900.md) | Proxy statement, period 2025-10-28 | 0001493152-25-019900 |
| 2025-10-22 | 16:35 ET | [8-K](/filings/0001493152-25-018922.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-018922 |
| 2025-10-20 | 17:22 ET | [8-K](/filings/0001493152-25-018684.md) | 5.07 Shareholder vote results | 0001493152-25-018684 |
| 2025-10-16 | 16:30 ET | [8-K](/filings/0001493152-25-018324.md) | 8.01 Other events | 0001493152-25-018324 |
| 2025-10-09 | 17:08 ET | [8-K](/filings/0001493152-25-017630.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-017630 |
| 2025-09-29 | 06:43 ET | [S-1](/filings/0001493152-25-015872.md) | Registration statement | 0001493152-25-015872 |
| 2025-09-26 | 17:10 ET | [8-K](/filings/0001493152-25-015775.md) | 8.01 Other events | 0001493152-25-015775 |
| 2025-09-18 | 16:27 ET | [8-K](/filings/0001493152-25-014071.md) | 8.01 Other events | 0001493152-25-014071 |
| 2025-09-15 | 10:05 ET | [DEF 14A](/filings/0001493152-25-013379.md) | Proxy statement, period 2025-09-15 | 0001493152-25-013379 |
| 2025-09-05 | 09:00 ET | [8-K](/filings/0001493152-25-012687.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-012687 |
| 2025-08-18 | 16:32 ET | [DEF 14A](/filings/0001641172-25-024628.md) | Proxy statement, period 2025-08-18 | 0001641172-25-024628 |
| 2025-08-11 | 16:26 ET | [10-Q](/filings/0000950170-25-106587.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106587 |
| 2025-07-25 | 19:00 ET | [8-K](/filings/0001641172-25-020896.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020896 |
| 2025-07-09 | 08:45 ET | [8-K](/filings/0001641172-25-018313.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018313 |
| 2025-05-27 | 08:41 ET | [S-1](/filings/0001641172-25-012405.md) | Registration statement | 0001641172-25-012405 |
| 2025-05-12 | 16:10 ET | [10-Q](/filings/0000950170-25-069204.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069204 |
| 2025-05-02 | 16:11 ET | [8-K](/filings/0001641172-25-008346.md) | 3.01 Delisting notice | 0001641172-25-008346 |
| 2025-03-24 | 16:20 ET | [10-K](/filings/0000950170-25-043859.md) | Annual report, period 2024-12-31 | 0000950170-25-043859 |
| 2024-12-16 | 16:00 ET | [8-K](/filings/0001493152-24-050203.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050203 |
| 2024-12-09 | 17:30 ET | [S-1/A](/filings/0001493152-24-049323.md) | Registration statement, amended | 0001493152-24-049323 |
| 2024-12-05 | 10:25 ET | [S-1/A](/filings/0001493152-24-048819.md) | Registration statement, amended | 0001493152-24-048819 |
| 2024-11-21 | 14:18 ET | [S-1/A](/filings/0001493152-24-047112.md) | Registration statement, amended | 0001493152-24-047112 |
| 2024-11-12 | 08:33 ET | [10-Q](/filings/0000950170-24-124664.md) | Quarterly report, period 2024-09-30 | 0000950170-24-124664 |
| 2024-10-30 | 06:05 ET | [S-1](/filings/0001493152-24-042973.md) | Registration statement | 0001493152-24-042973 |
| 2024-09-27 | 16:31 ET | [8-K](/filings/0001493152-24-038547.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-038547 |
| 2024-08-12 | 16:11 ET | [10-Q](/filings/0000950170-24-095432.md) | Quarterly report, period 2024-06-30 | 0000950170-24-095432 |
| 2024-07-08 | 17:15 ET | [8-K](/filings/0001493152-24-026504.md) | 5.07 Shareholder vote results | 0001493152-24-026504 |
| 2024-05-22 | 16:45 ET | [DEF 14A](/filings/0001493152-24-021034.md) | Proxy statement, period 2024-05-22 | 0001493152-24-021034 |
| 2024-05-13 | 16:07 ET | [10-Q](/filings/0000950170-24-058644.md) | Quarterly report, period 2024-03-31 | 0000950170-24-058644 |
| 2024-05-10 | 16:52 ET | [8-K](/filings/0001493152-24-018687.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-018687 |
| 2024-05-03 | 16:56 ET | [8-K](/filings/0001493152-24-017739.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-017739 |
| 2024-04-10 | 17:29 ET | [8-K](/filings/0001493152-24-014253.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-014253 |
| 2024-04-05 | 16:30 ET | [8-K](/filings/0001493152-24-013336.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-013336 |
| 2024-03-27 | 16:45 ET | [8-K](/filings/0001493152-24-011527.md) | 2.02 Results of operations; 3.01 Delisting notice; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-011527 |
| 2024-03-26 | 16:06 ET | [10-K](/filings/0000950170-24-036402.md) | Annual report, period 2023-12-31 | 0000950170-24-036402 |
| 2024-03-06 | 16:35 ET | [8-K](/filings/0001493152-24-009042.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-009042 |
| 2024-02-13 | 16:38 ET | [8-K](/filings/0001493152-24-006132.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-006132 |
| 2024-02-06 | 17:00 ET | [DEF 14A](/filings/0001493152-24-005117.md) | Proxy statement, period 2024-02-06 | 0001493152-24-005117 |
| 2024-02-01 | 06:02 ET | [8-K](/filings/0001493152-24-004539.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-004539 |
| 2024-01-29 | 08:30 ET | [8-K](/filings/0001493152-24-004066.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004066 |

Page 1 of 10. [Older](/companies/pali/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:35 ET. No prices; not investment advice.